MedEnrich | Página principal
Continue Watching
últimos vidéos
últimos vidéos
Brightcove Home Latest Listing
Cáncer de mama
Cáncer de mama
Brightcove Cards Listing
Cáncer de próstata
Brightcove Cards Listing
Mieloma múltiple
Mieloma múltiple
Brightcove Cards Listing
Popular en MedEnrich
Popular in Sin nombre
Myelodysplastic Syndromes31m 24s
Improving Diagnosis of MDS -Innovative Solutions
Modern Web -Based digital tools based on 10 routinely used clinical parameters and Gradient Based Model can help in non-invasive diagnosis of MDS.
mds diagnosis
web based diagnosis
her2negative mbc
1
Improving Diagnosis of MDS -Innovative Solutions
Cancer de prostata6m 1s
Androgen Receptor Targeted Therapies in patients with Cardiovascular Co Morbidities
Referring the patients to cardiologist is an important aspect of managing patients with cardiovascular co-morbidities.
hypertension
cardiac events
cardiovascular co-morbidities
1
Androgen Receptor Targeted Therapies in patients...
Mieloma múltiple3m 12s
Tips for Optimising Long Term Lenalidomide Maintenance in Multiple Myeloma
Dr. Joseph Mikhael explains the triad of maintaining the patients on term Lenalidomide maintenance.
long term maintenance therapy
lenalidomide
tips
1
Tips for Optimising Long Term Lenalidomide...
Cáncer de mama3m 56s
Duration of trastuzumab in patients with Her2 positive Metastatic Breast Cancer in prolonged remission
There are no randomized clinical trials addressing the continued use of Trastuzumab for Her2 positive MBC patients in prolonged remission and has become important and relevant clinical question.
her2 positive mbc
prolonged remission
trastuzumab duration
1
Duration of trastuzumab in patients with Her2...
Mieloma múltiple8m 23s
Treatment of High Risk Myeloma Patients
While treating high risk patients it is critical to address complex biology & maximize the response for individual patients by gaining depth of response & maintaining that response for long duration. To ensure good quality of life patients should hav
high risk myeloma
1
Treatment of High Risk Myeloma Patients
Mieloma múltiple4m 12s
Key Practice Points -Myeloma Related Renal Impairment
In patients with renal impairment primary goal is improvement of Renal Function which is associated with improved treatment outcomes. 50% of patients present renal impairment and renal impairment is severe in 15% of patients.
myeloma
renal impairment
key practice points
1
Key Practice Points -Myeloma Related Renal...
Myelodysplastic Syndromes7m 3s
Clinical Application of Web Based Tool for Improving MDS Diagnosis
Gradient Based Model based on 10 routinely used parameters (Age, Gender, Hb, WBC, MCV, Platelets, Neutrophils, Monocytes, Glucose, Creatinine) is now available to facilitate non-invasive diagnosis of MDS.
mds
non-invasive diagnosis
1
Clinical Application of Web Based Tool for...
Mieloma múltiple7m 22s
Using Bone Targeted Therapy in Special Situations in Multiple Myeloma
Bone targeting agents have different toxicities and rare complications which are dependent on the exposure to the specific treatment. Watch detailed video on MedEnrich on use of bone targeted agent in Multiple Myeloma
bisphosphonates
renal insufficiency
hypercalcemia
1
Using Bone Targeted Therapy in Special Situations...
Mieloma múltiple10m 40s
Recommendations -Management of Myeloma Related Renal Impairment
Supportive Care, Mechanical Approach and Systemic Antimyeloma treatment are 3 pillars of management of Myeloma related renal impairment. In supportive care prompt initiation of high fluid administration, appropriate use of Bisphosphonates can help.
myeloma
renal impairment
lancet guidelines
1
Recommendations -Management of Myeloma Related...
Mieloma múltiple10m 19s
CAR -T cells in Lymphoma
CAR-T cell therapies are approved for treatment of Diffuse Large B Cell Lymphoma (DLBCL) , Follicular Lymphoma & Mantle Cell Lymphoma.
car-t cell therapy
high risk lymphoma
1
CAR -T cells in Lymphoma
Seminarios web anteriores
Seminarios web anteriores
Webinar Cards Listing
Artículos
Artículos
Medbytes Cards Listing
Inicie sesión
Por favor inicie sesión para acceder a todo el contenido de MedEnrich
¿Es nuevo/a en MedEnrich? Regístrese ahora